News from

Health & Medicine

Reset All Filters
246 Results
Penn Nursing dean contributes to Aspen Health Strategy Group Report Urging Action on Youth Mental Health

Penn Nursing dean contributes to Aspen Health Strategy Group Report Urging Action on Youth Mental Health

A new report from the Aspen Health Strategy Group, “Addressing the Child & Adolescent Mental Health Crisis,” emphasizes the urgent need for health sector leadership in addressing the growing youth mental health crisis; Penn Nursing Dean Antonia M. Villarruel is one of 20 contributors.

American Dental Association and Penn Dental Medicine announce first Living Guideline Program in oral health
(Left to right) Olivia Urquhart, Michael Glick, and Alonso Carrasco-Labra.

(Left to right) Olivia Urquhart, Michael Glick, and Alonso Carrasco-Labra of Penn Dental’s Center for Integrative Global Oral Health (CIGOH).

(Image: Kevin Monko)

American Dental Association and Penn Dental Medicine announce first Living Guideline Program in oral health

The groundbreaking program will provide evidence-informed guidelines in real time to support patient care and advance public health.

2 min. read

A mothers’ meetup like no other for families formed through uterus transplant
Two people embrace at a uterine transplant meetup lunch with a baby in a stroller and gifts on a conference table.

Image: Courtesy of Penn Medicine News

A mothers’ meetup like no other for families formed through uterus transplant

One week before Mother’s Day, those who gave birth through uterus transplant gathered for a special brunch with those who donated their uteruses for the procedure, and their respective families.

Alex Gardner

2 min. read

Philly CEAL trains health workers in chronic disease management

Philly CEAL trains health workers in chronic disease management

Community health workers from Philadelphia recently completed intensive training in chronic disease self-management through the Philly CEAL project, a strategic partnership between Penn Nursing and the city’s Office of Community Empowerment and Opportunity.

Promising inhibitor combination for hard-to-treat leukemia subtypes
Andres Blanco in a lab at Penn Vet.

Andrés Blanco is an assistant professor of biomedical science at Penn’s School of Veterinary Medicine.

(Image: John Donges)

Promising inhibitor combination for hard-to-treat leukemia subtypes

Researchers from Penn Vet and other institutions have identified a novel inhibitor combination of molecules that induce terminal differentiation for the treatment of human non-APL subtypes of AML.

From Penn Vet

2 min. read

Soon-to-be-graduate hopes to deliver primary care to rural communities
Chip Chambers stands on college campus.

nocred

Soon-to-be-graduate hopes to deliver primary care to rural communities

Fueled by his faith, Chip Chambers, a fifth-year M.D./M.B.A. student in the Perelman School of Medicine and Wharton School, has always looked for ways to serve.“My faith is a huge motivator of everything that I do. I just believe that I’ve been blessed with a lot of things that I didn’t earn and that I have a responsibility to steward those for the good of other people and not for myself,” Chambers says.

4 min. read

Enhanced CAR T cell therapy offers new strategy for lymphoma
3-D rendering of chimeric antigen receptor T (CAR-T) cell therapy, a treatment for a variety of cancers

Image: iStock/Naeblys

Enhanced CAR T cell therapy offers new strategy for lymphoma

A new study from Penn Medicine marks a significant development in the ongoing evolution of CAR T cell therapy, as a novel cytokine-enhanced CAR T that has been tested in patients with blood cancer shows robust response rates.

2 min. read

First new subtype of Castleman disease discovered in 45 years
David Fajgenbaum in his lab.

David Fajgenbaum is an assistant professor of medicine at the Perelman School of Medicine at the University of Pennsylvania and associate director of patient impact in the Penn Orphan Disease Center. He also leads the Castleman Disease Research Program.

(Image: Courtesy of Penn Medicine)

First new subtype of Castleman disease discovered in 45 years

A new study co-authored by Penn Medicine’s David Fajgenbaum expands the spectrum of the rare disorder, which will help diagnose and treat patients caught between existing classification systems.

2 min. read